Detrol (tolterodine tartrate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved March 1998

Specific Treatments:

overactive bladder

Therapeutic Areas

General Information

Detrol tablets have been approved for the treatment of overactive bladder.

Clinical Results

Results from three placebo-controlled, 12-week studies including almost 2,000 adult patients with overactive bladder symptoms showed a significant reduction, 15 to 21% in the median number of urinations per 24 hours, a significantly greater reduction than the change in placebo patients. In addition, incontinence episodes decreased by 50 to 56% from baseline in treated patients.